Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Abbot R. Laptook, MD
Brown University, Women & Infants Hospital of Rhode Island
Principal Investigator - Abhik Das, PhD
RTI International
Principal Investigator - Barbara J. Stoll, MD
Emory University
Principal Investigator - Brenda B. Poindexter, MD MS
Indiana University
Principal Investigator - Dale L. Phelps, MD
University of Rochester
Principal Investigator - Edward F Bell, MD
University of Iowa
Principal Investigator - Ivan D. Frantz III, MD
Tufts Medical Center
Principal Investigator - Kathleen A. Kennedy, MD MPH
The University of Texas Health Science Center, Houston
Principal Investigator - Krisa P. Van Meurs, MD
Stanford University
Principal Investigator - Kristi L. Watterberg, MD
University of New Mexico
Principal Investigator - Kurt Schibler, MD
Children's Hospital Medical Center, Cincinnati
Principal Investigator - Michele C. Walsh, MD MS
Case Western Reserve University, Rainbow Babies and Children's Hospital
Principal Investigator - Pablo J. Sanchez, MD
University of Texas, Southwestern Medical Center at Dallas
Principal Investigator - Richard A. Ehrenkranz, MD
Yale University
Principal Investigator - Roger G. Faix, MD
University of Utah
Principal Investigator - Ronald N. Goldberg, MD
Duke University
Principal Investigator - Seetha Shankaran, MD
Wayne State University
Principal Investigator - Waldemar A. Carlo, MD
University of Alabama at Birmingham
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Stanford University
Palo Alto, California, United States
- Yale University
New Haven, Connecticut, United States
- Emory University
Atlanta, Georgia, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Iowa
Iowa City, Iowa, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Wayne State University
Detroit, Michigan, United States
- University of New Mexico
Albuquerque, New Mexico, United States
- University of Rochester
Rochester, New York, United States
- Duke University
Durham, North Carolina, United States
- Rti International
Durham, North Carolina, United States
- Case Western Reserve University, Rainbow Babies and Children'S Hospital
Cleveland, Ohio, United States
- Brown University, Women & Infants Hospital of Rhode Island
Providence, Rhode Island, United States
- University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, United States
- University of Texas Health Science Center at Houston
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2010
- Primary completion
- 31 May 2011
- Completion
- 30 Sept 2013
- Last update posted
- 14 Jun 2022
- Registered enrollment
- 125
- Registry id
- NCT01030575
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.